Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

COC treatment improves hormone and metabolic levels in PCOS patients.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

High testosterone increases heart disease risk in women with PCOS.

Spironolactone treatment increases the amount of testosterone available in the body.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Salivary cytokines and the Free Androgen Index are promising non-invasive markers for diagnosing PCOS.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.